G

Genmab

Organization

Heard in 5 episodes across 2 shows since Aug 2026

Genmab A/S is an international biotechnology company specializing in the development of antibody therapeutics for the treatment of cancer and other serious diseases. Founded in 1999 and headquartered in Copenhagen, Denmark, the company operates globally with research and development facilities in several countries.

Episodes

5
across 2 shows

First heard

Aug 2026

Expert statements

6
6 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20260
Oct 20264
Nov 20260

Email alert

Email me when Genmab comes up on a podcast

One email a week at most, with the new episodes that mention Genmab. Free, no account needed, unsubscribe in one click.

What experts have said about Genmab

6 statements · 6 positive

  1. Yaron WerberPositiveOct 30, 2026· Biotech Hangout

    Genmab’s ovarian-cancer trial showed a 60–70% reduction in death.

    “with a 60% to 70% reduction in death.”

    Listen at 54:42

    Open the episode · Episode 201 - October 30, 2026
  2. Yaron WerberPositiveOct 30, 2026· Biotech Hangout

    Genmab’s strong oncology data may justify a higher stock valuation.

    “this is a stock that you could see is now getting remunerated”

    Listen at 56:48

    Open the episode · Episode 201 - October 30, 2026
  3. Anna EdwardsPositiveOct 6, 2026· Stock Movers

    Genmab and AbbVie’s combination medicine reduced lymphoma progression or death risk by over 50%.

    “it's cutting the risk of disease progression or death by more than 50%”

    Listen at 0:58

    Open the episode · Genmab Gains, Sabadell Rises, Vend Tumbles

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

5 episodes featuring Genmab, newest first